<DOC>
	<DOCNO>NCT00774761</DOCNO>
	<brief_summary>The purpose study evaluate systemic exposure pharmacodynamics two dos nebulized fluticasone/formoterol combination compare monocomponents .</brief_summary>
	<brief_title>A Study Evaluating Systemic Exposure Pharmacodynamics Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Able understand requirement study provide consent Medical diagnosis COPD A current prior history least 10pack year cigarette smoke Female childbearing potential use adequate birth control Diagnosis asthma Other significant disease COPD Has donate unit blood within 30 day study , intend donate QTc great 0.460 second Subjects radiation chemotherapy previous 12 month Subjects lung resection History illegal drug abuse alcohol abuse within past 5 year</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Chronic</keyword>
	<keyword>Obstructive</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>